Pierre-Marie Morice

9PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 05, 2026
Ischaemic stroke and 5-fluorouracil or capecitabine: A systematic review and meta-analysis of harms and a retrospective study of the WHO pharmacovigilance database.

|Oct 14, 2024
Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.

Pierre-Marie Morice, Sabine Khalife-Hachem, Marion Sassier

|Jan 25, 2024
Arterial hypertension associated with PARPi: A meta-analysis of 41 placebo randomized controlled trials combined with a World Health Organization's pharmacovigilance study.

Clémence Blaize, Ellina Surtouque, Jonaz Font

|Mar 14, 2023
Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Response.

Vincent Marmouset, Pierre-Marie Morice, Arnaud Pagès

|Oct 06, 2022
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.

Vincent Marmouset, Justine Decroocq, Sylvain Garciaz

|Sep 02, 2022
Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.

Sophie Nguyen, Etienne Bastien, Basile Chretien

Pageof 2

Frequent Collaborators

4 joint publications

Charles Dolladille

3 joint publications

Jean-Baptiste Micol

2 joint publications

Angélique Da-Silva

2 joint publications

Alexandra Leary